Furthermore, manipulating macrophage polarization toward the M1 phenotype by enhancing STAT1 phosphorylation while suppressing STAT3 activity has also shown therapeutic promise in other malignancies, including glioblastoma 41. The gene discussed is STAT3; the disease is glioblastoma.